MedTrace Logo

Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure

NCT06079034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5058

Last updated 2024-04-04

No results posted yet for this study

Summary

There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences in rate of intracranial hemorrhage and ischemic stroke between venovenous (VV) and VA ECMO among infants with respiratory failure where clinicians may choose either strategy.

This project is a retrospective review of data in the ELSO registry.

Conditions

Interventions

PROCEDURE

Venovenous ECMO

Initial support type of venovenous ECMO via a dual-lumen on two-site VV ECMO cannulation strategy

PROCEDURE

Venoarterial ECMO

Initial support type of venoarterial ECMO

Sponsors & Collaborators

Principal Investigators

  • Joseph G Kohne · University of Michigan

Eligibility

Min Age
0 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-18
Primary Completion
2023-12-12
Completion
2023-12-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06079034 on ClinicalTrials.gov